Product NDC: | 0019-N180 |
Proprietary Name: | GALLIUM CITRATE GA-67 |
Non Proprietary Name: | gallium citrate ga-67 |
Active Ingredient(s): | 2 mCi/mL & nbsp; gallium citrate ga-67 |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0019-N180 |
Labeler Name: | Mallinckrodt Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA018058 |
Marketing Category: | NDA |
Start Marketing Date: | 20080221 |
Package NDC: | 0019-N180-M0 |
Package Description: | 1 VIAL in 1 CAN (0019-N180-M0) > 6.6 mL in 1 VIAL |
NDC Code | 0019-N180-M0 |
Proprietary Name | GALLIUM CITRATE GA-67 |
Package Description | 1 VIAL in 1 CAN (0019-N180-M0) > 6.6 mL in 1 VIAL |
Product NDC | 0019-N180 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | gallium citrate ga-67 |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20080221 |
Marketing Category Name | NDA |
Labeler Name | Mallinckrodt Inc. |
Substance Name | GALLIUM CHLORIDE GA-67 |
Strength Number | 2 |
Strength Unit | mCi/mL |
Pharmaceutical Classes |